1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12-49.
2.
Singh D, Vignat J, Lorenzoni V et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 2023; 11: e197-e206.
3.
Tewari KS. Cervical cancer. N Engl J Med 2025; 392: 56-71.
4.
Fokdal L, Sturdza A, Mazeron R et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol 2016; 120: 434-440.
5.
Mendez LC, Weiss Y, D’Souza D et al. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities. Radiother Oncol 2017; 123: 312-318.
6.
Kamran SC, Manuel MM, Cho LP et al. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix. Gynecol Oncol 2017; 145: 284-290.
7.
Ribeiro I, Janssen H, De Brabandere M et al. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Radiother Oncol 2016; 120: 447-454.
8.
Report 89. J ICRU 2013; 13: NP.
9.
Pötter R, Tanderup K, Kirisits C et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60.
10.
Yang X, Ren H, Li Z, Fu J. Brachytherapy for cervical cancer: from intracavitary to interstitial technique. Front Oncol 2024; 14: 1442712.
11.
Petitt MS, Ackerman RS, Hanna MM et al. Anesthetic and analgesic methods for gynecologic brachytherapy: A meta-analysis and systematic review. Brachytherapy 2020; 19: 328-336.
12.
Lim KH, Lu JJ, Wynne CJ et al. A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer. Am J Clin Oncol 2004; 27: 449-451.
13.
Dankulchai P, Thanamitsomboon N, Sittiwong W et al. Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer. J Contemp Brachytherapy 2024; 16: 193-201.
14.
Singhal S, Veeratterapillay J, Locks S et al. Magnetic resonance imaging-guided adaptive brachytherapy for the treatment of cervical cancer and its impact on clinical outcome. Clin Oncol (R Coll Radiol) 2022; 34: 442-451.
15.
Mohammed KE, Nagar T, Pearson SM et al. Dosimetric comparison of high-dose rate cervix brachytherapy with and without interstitial needles and the impact on target volume coverage, and organ at risk constraints. J Med Imaging Radiat Oncol 2022; 66: 671-677.
16.
Baltas D, Kolotas C, Geramani K et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998; 40: 515-524.
17.
Priean VG, Aggarwal LM, Mourya A et al. A dosimetric study to evaluate the inverse planning simulated annealing (IPSA) and hybrid inverse planning optimization (HIPO) algorithms in HDR brachytherapy of cervical cancer. J Cancer Res Ther 2025; 21: 576-582.
18.
van’t Riet A, Mak AC, Moerland MA et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 731-736.
19.
Francoeur AA, Monk BJ, Tewari KS. Treatment advances across the cervical cancer spectrum. Nat Rev Clin Oncol 2025; 22: 182-199.
20.
Ke T, Wang J, Zhang N et al. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study. Strahlenther Onkol 2023; 199: 131-140.
21.
Murakami N, Ando K, Murata M et al. An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma. J Radiat Res 2022; 63: 412-427.
22.
Wang Y, Zhang T, Peng S et al. Patterns of treatment failure after concurrent chemoradiotherapy or adjuvant radiotherapy in patients with locally advanced cervical cancer. Oncol Res Treat 2021; 44: 76-85.
23.
Arya R, Giurcanu M, Jutzy JM et al. Local control and use of external beam parametrial boost in the era of image-guided brachytherapy for locally advanced cervical cancer. Am J Clin Oncol 2021; 44: 565-571.
24.
Elledge CR, LaVigne AW, Bhatia RK, Viswanathan AN. Aiming for 100% local control in locally advanced cervical cancer: the role of complex brachytherapy applicators and intraprocedural imaging. Semin Radiat Oncol 2020; 30: 300-310.
25.
Pinn-Bingham M, Puthawala AA, Syed AM et al. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results. Int J Radiat Oncol Biol Phys 2013; 85: 714-720.
26.
Scanderbeg DJ, Yashar C, Ouhib Z et al. Development, implementation, and associated challenges of a new HDR brachytherapy program. Brachytherapy 2020; 19: 874-880.
27.
Chen J, Zhang N, Liu Y et al. Analysis of applicator insertion related acute side effects for cervical cancer treated with brachytherapy. Front Oncol 2021; 11: 677052.
28.
Kirisits C, Rivard MJ, Baltas D et al. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM. Radiother Oncol 2014; 110: 199-212.
29.
Jamadagni S, Ponni Tr A, Revathy P. Dosimetric comparison of intra-cavitary brachytherapy technique with free-hand (intra-cavitary + interstitial) technique in cervical cancer. J Contemp Brachytherapy 2024; 16: 28-34.
